Consistent with this, we found that the mean of CXXC5 expression is higher in ERα+ luminal breast tumors compared to that observed with normal-like and ERα-negative breast cancer subtypes, including HER2+ and Basal-like tumors (Fig. 5b,c). This evidence concerns the gene CXXC5 and breast carcinoma.